FlareHawk
Device Thoracolumbar spine
General payments
$6,769,390
Research payments
$0
Through program year 2024, $6,769,390 in general payments and $0 in research payments were reported against FlareHawk (Thoracolumbar spine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $1,245,526 | 218 |
| 2023 | General | $951,412 | 518 |
| 2022 | General | $1,322,201 | 218 |
| 2021 | General | $1,230,009 | 1,089 |
| 2020 | General | $1,104,960 | 306 |
| 2019 | General | $915,282 | 506 |
Breakdown
The top 5 of 42 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
2,855 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.